The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKrm22 Plc Regulatory News (KRM)

Share Price Information for Krm22 Plc (KRM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 27.50
Bid: 25.00
Ask: 30.00
Change: 0.00 (0.00%)
Spread: 5.00 (20.00%)
Open: 27.50
High: 27.50
Low: 27.50
Prev. Close: 27.50
KRM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

31 Jan 2022 07:00

RNS Number : 0366A
KRM22 PLC
31 January 2022
 

KRM22 plc

("KRM22", the "Group" or the "Company")

Trading Update

Notice of Results

 

KRM22 plc, (AIM: KRM) the technology and software investment company that focuses on risk management for capital markets, today announces the following trading update for the 12 month period to 31 December 2021 ("FY2021").

Financial Highlights

· Gross cash as at 31 December 2021 of £5.4m (FY2020: £2.0m)

· ARR at 31 December 2021 of £3.8m (FY2020: £4.1m)

o New contracted ARR in the year of £0.7m (FY2020: £0.8m)

· Total revenue recognised of approximately £4.1m (FY2020: £4.6m)

· Adjusted EBITDA loss of £0.8m (FY2020: loss of £0.3m)

 

FY2021 has seen KRM22 successfully sign multi-year contracts with new customers as well as transitioning customers, inherited from legacy acquisitions, on to new multi-year contracts. However, this progress was more than offset by churn from a subset of those legacy customers. In addition, a new contract with a global "tier one" bank, expected to be signed in the fourth quarter of FY2021, has been delayed to 2022. The Company's cost base increased in FY2021 compared to the prior year due to the reinstatement of salaries in order to ensure retention of key staff, expand the Global Risk Platform and the extension of the Company's risk management products. This all resulted in lower revenue recognised and an increase in adjusted EBITDA loss compared to FY2020 and overall results [slightly] lower than current market expectations.

Following the completion of the subscription for 25 per cent of the enlarged share capital of KRM22 by Trading Technologies International, Inc ("TT") in December, the Company has a strong balance sheet with cash at 31 December 2021 of £5.4m, providing a stable platform to pursue the opportunity within risk management which the Board feels remain firmly in place. The Company also has a list of sales prospects which, combined with the new distribution agreement with TT, will underpin future growth. 2022 will be a transitional year and the Company expects to add sales, marketing, and development resource to support both its direct sales efforts and the TT distribution agreement, but the pace of this investment will need to be considered against the prevailing challenging business environment.

Financial expectations noted above are preliminary, and subject to year-end financial close and audit review processes. Full year results will be announced on 2 March 2022.

Keith Todd CBE, Executive Chairman at KRM22 commented: "The 2021 financial performance masks the significant progress the Company has made strategically, with significant expansion of offerings on the Global Risk Platform and the continued migration of many customers to new multi-year contracts as well as new revenue contract wins. The recently signed distribution agreement with Trading Technologies will expand the Companies' growth opportunities under Stephen Casner's leadership as CEO."

 

For further information please contact:

 

KRM22 plc InvestorRelations@krm22.com

 

Keith Todd CBE, Executive Chairman

Stephen Casner, CEO

Kim Suter, CFO

 

finnCap Ltd (Nominated Adviser and Sole Broker) +44 (0)20 7220 0500

Carl Holmes / Kate Bannatyne

Alice Lane / Sunila de Silva (ECM)

 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

About KRM22 plc

KRM22 is a closed-ended investment company which listed on AIM on 30 April 2018. The Company has been established with the objective of creating value for its investors through the investment in, and subsequent growth and development of, target companies in the technology and software sector, with a focus on risk management in capital markets.

 

Through its investments and the Global Risk Platform, KRM22 helps capital market companies reduce the cost and complexity of risk management. The Global Risk Platform provides applications to help address firms' market, compliance, operations and technology risk challenges and to manage their entire enterprise risk profile.

 

Capital markets companies' partner with KRM22 to optimise risk management systems and processes, improving profitability and expanding opportunities to increase portfolio returns by leveraging risk as alpha.

 

KRM22 plc is listed on AIM and the Group is headquartered in London, with offices in several of the world's major financial centres.

 

See more about KRM22 at www.krm22.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSEFFMAEESESF
Date   Source Headline
3rd Jun 20197:00 amRNSCompletion of Acquisition
31st May 20197:00 amRNSKRM22 announces partnership with Trailight Ltd
30th May 20197:00 amRNSAcquisition of Object+
1st May 20197:00 amRNSUpdate on Fundraising
30th Apr 20197:00 amRNSDirectorate Changes
29th Apr 20197:00 amRNSDebt Facility Secured
16th Apr 20195:30 pmRNSDirector/PDMR Shareholding
16th Apr 201910:00 amRNSKRM22 launches conduct risk training offering
11th Apr 20197:00 amRNSHolding(s) in Company
3rd Apr 20197:00 amRNSFundraising
11th Mar 20199:29 amRNSKRM22 launches Enterprise Risk Cockpit
5th Mar 20197:00 amRNSDirectorate Change
21st Jan 201911:33 amRNSResult of General Meeting
4th Jan 20197:00 amRNSNotice of GM
29th Nov 20187:00 amRNSKRM22 announces new customer contracts
6th Nov 20187:00 amRNSKRM22 announces partnership with Vector Risk
3rd Oct 201811:18 amRNSHolding(s) in Company
3rd Oct 201811:17 amRNSHolding(s) in Company
1st Oct 20181:01 pmRNSHolding(s) in Company
27th Sep 20183:52 pmRNSHolding(s) in Company
25th Sep 20185:38 pmRNSCompletion of Acquisition
25th Sep 20183:32 pmRNSAcquisition
25th Sep 20187:00 amRNSHalf-year Report
16th Aug 201810:55 amRNSChange of Registered Office
17th Jul 20187:00 amRNSSubject Matter Experts Acquired in Enterprise Risk
12th Jul 20187:00 amRNSIrisium New Customer Contract
11th Jul 20187:00 amRNSKRM22 partnership with Ascent Technologies Inc
27th Jun 20185:12 pmRNSHolding(s) in Company
5th Jun 20187:00 amRNSAcquisition
3rd May 20188:04 amRNSHolding(s) in Company
2nd May 20184:32 pmRNSDirector/PDMR Shareholding
1st May 20186:09 pmRNSHolding(s) in Company
1st May 20182:18 pmRNSHolding(s) in Company
30th Apr 20188:45 amRNSGrant of Warrant
30th Apr 20188:00 amRNSAdmission to AIM and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.